APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 325 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $209,929 | -26.3% | 3,507 | +12.1% | 0.12% | -28.5% |
| Q2 2023 | $284,961 | +27.9% | 3,128 | -7.4% | 0.16% | +19.6% |
| Q1 2023 | $222,813 | -24.7% | 3,378 | -41.0% | 0.14% | -31.7% |
| Q4 2022 | $296,040 | -89.5% | 5,725 | -86.2% | 0.20% | -89.6% |
| Q3 2022 | $2,825,000 | +769.2% | 41,365 | +476.2% | 1.94% | +742.0% |
| Q2 2022 | $325,000 | -7.1% | 7,179 | +4.4% | 0.23% | +4.1% |
| Q1 2022 | $350,000 | -38.6% | 6,879 | -43.0% | 0.22% | -36.6% |
| Q4 2021 | $570,000 | +172.7% | 12,060 | +264.4% | 0.35% | +171.3% |
| Q2 2021 | $209,000 | -11.8% | 3,310 | -40.1% | 0.13% | -15.7% |
| Q1 2021 | $237,000 | -27.5% | 5,523 | -3.4% | 0.15% | -31.7% |
| Q4 2020 | $327,000 | – | 5,718 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 624,962 | $20,599,000 | 13.29% |
| Octagon Capital Advisors LP | 1,595,911 | $52,601,000 | 12.95% |
| Logos Global Management LP | 1,450,000 | $47,792,000 | 3.45% |
| Avoro Capital Advisors LLC | 5,000,000 | $164,800,000 | 2.59% |
| Ghost Tree Capital, LLC | 200,000 | $6,592,000 | 1.93% |
| Integral Health Asset Management, LLC | 190,000 | $6,262,000 | 1.80% |
| GREAT POINT PARTNERS LLC | 200,000 | $6,592,000 | 1.54% |
| Aufman Associates Inc | 53,642 | $1,768,000 | 1.45% |
| Ghost Tree Capital, LLC | 150,000 | $4,944,000 | 1.45% |
| Altium Capital Management LP | 166,700 | $5,494,000 | 1.44% |